A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III (Q71906621)
Jump to navigation
Jump to search
scientific article published on 01 November 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III |
scientific article published on 01 November 1996 |
Statements
A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III (English)
1 November 1996